Long-Term Efficacy of Guselkumab on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through Two Years of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Biologic-Naïve Patients With Psoriatic Arthritis
September 2023
in “
Journal of the American Academy of Dermatology
”